In vitro reversion of activated primary human hepatic stellate cells

Fibrogenesis and Tissue Repair

Volumn 8, Issue 1, 2015, Pages

  El Taghdouini, Adil ^a   Najimi, Mustapha ^b   Sancho Bru, Pau ^c   Sokal, Etienne ^b   van Grunsven, Leo A ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Fibrosis; Gene expression profiling; Hepatic stellate cells; Inactivation; Quiescent; Reversion

Indexed keywords

EPIDERMAL GROWTH FACTOR; FAT DROPLET; FIBROBLAST GROWTH FACTOR 2; MATRIX METALLOPROTEINASE; OLEIC ACID; PALMITIC ACID; RETINOL; TRANSFORMING GROWTH FACTOR BETA;

ACTA2 GENE; ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; CTSS GENE; CXCL1 GENE; CXCL2 GENE; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFANT; LOX GENE; MALE; NONHUMAN; PHENOTYPE; REVERTANT; SCHOOL CHILD; STELLATE CELL; UPREGULATION;

EID: 84938497014     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/s13069-015-0031-z     Document Type: Article

References (59)

1. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115(2):209-18.
2. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18(7):1028-40.
3. Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013;4:2823. doi:10.1038/ncomms3823.
4. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88(1):125-72. doi:10.1152/ physrev.00013.2007.
5. Reynaert H, Urbain D, Geerts A. Regulation of sinusoidal perfusion in portal hypertension. Anat Rec. 2008;291(6):693-8. doi:10.1002/ar.20669.
6. Taura K, De Minicis S, Seki E, Hatano E, Iwaisako K, Osterreicher CH, et al. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis. Gastroenterology. 2008;135(5):1729-38. http://dx.doi.org/ 10.1053/j.gastro.2008.07.065.
7. Geerts ABL, Wisse E. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis. 2001;21:311-35.
8. Ellis EL, Mann DA. Clinical evidence for the regression of liver fibrosis. J Hepatol. 2012;56(5):1171-80. http://dx.doi.org/10.1016/j.jhep.2011.09.024.
9. Iredale JPBRC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest. 1998;102:538-49.
10. Issa R, Williams E, Trim N, Kendall T, Arthur MJP, Reichen J, et al. Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut. 2001;48(4):548-57. doi:10.1136/ gut.48.4.548.
11. Hazra S, Xiong S, Wang J, Rippe RA, Krishna V, Chatterjee K, et al. Peroxisome proliferator-activated receptor γ induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem. 2004;279(12):11392-401. doi:10.1074/jbc.M310284200.
12. She H, Xiong S, Hazra S, Tsukamoto H. Adipogenic transcriptional regulation of hepatic stellate cells. J Biol Chem. 2005;280(6):4959-67. doi:10.1074/jbc.M410078200.
13. Kisseleva T, Cong M, Paik Y, Scholten D, Jiang C, Benner C, et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci. 2012;109(24):9448-53. doi:10.1073/ pnas.1201840109.
14. Troeger JS, Mederacke I, Gwak GY, Dapito DH, Mu X, Hsu CC, et al. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology. 2012;143(4):1073-83.e22. http://dx.doi.org/10.1053/ j.gastro.2012.06.036.
15. Liu XXJ, Brenner DA, Kisseleva T. Reversibility of liver fibrosis and inactivation of fibrogenic myofibroblasts. Curr Pathobiol Rep. 2013;1(3):209-14.
16. Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T. Hepatic stellate cell/ myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol. 2002;36(2):200-9. http://dx.doi.org/10.1016/S0168-8278(01)00260-4.
17. Niki T, Pekny M, Hellemans K, De Bleser P, Van Den Berg K, Vaeyens F, et al. Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells. Hepatology. 1999;29(2):520-7. doi:10.1002/ hep.510290232.
18. Niki T, De Bleser PJ, Xu G, Van der Berg K, Wisse E, Geerts A. Comparison of glial fibrillary acidic protein and desmin staining in normal and CCl4-induced fibrotic rat livers. Hepatology. 1996;23(6):1538-45. doi:10.1002/hep.510230634.
19. D'Ambrosio DN, Walewski JL, Clugston RD, Berk PD, Rippe RA, Blaner WS. Distinct populations of hepatic stellate cells in the mouse liver have different capacities for retinoid and lipid storage. PLoS One. 2011;6(9), e24993. doi:10.1371/journal.pone.0024993.
20. Hammel P, Couvelard A, O'Toole D, Ratouis A, Sauvanet A, Fléjou JF, et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. New Engl J Med. 2001;344(6):418-23. doi:10.1056/NEJM200102083440604.
21. Kweon Y-O, Goodman ZD, Dienstag JL, Schiff ER, Brown NA, Burkhardt E, et al. Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol. 2001;35(6):749-55. http://dx.doi.org/10.1016/S0168-8278(01)00218-5.
22. Arthur MJP. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology. 2002;122(5):1525-8. http://dx.doi.org/10.1053/ gast.2002.33367.
23. Dixon JB, Bhathal PS, Hughes NR, O'Brien PE. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology. 2004;39(6):1647-54. doi:10.1002/hep.20251.
24. Abdalla A, Zalata K, Ismail A, Shiha G, Attiya M, Abo-Alyazeed A. Regression of fibrosis in paediatric autoimmune hepatitis: morphometric assessment of fibrosis versus semiquantitative methods. Fibrogenesis Tissue Repair. 2009;2(1):2.
25. Kömüves LG, Feren A, Jones AL, Fodor E. Expression of epidermal growth factor and its receptor in cirrhotic liver disease. J Histochem Cytochem. 2000;48(6):821-30. doi:10.1177/002215540004800610.
26. Olsen PS, Boesby S, Kirkegaard P, Therkelsen K, Almdal T, Poulsen SS, et al. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology. 1988;8(5):992-6. doi:10.1002/hep.1840080503.
27. Hoshida Y, Villanueva A, Sangiovanni A, Sole M, Hur C, Andersson KL, et al. Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology. 2013;144(5):1024-30. http://dx.doi.org/ 10.1053/j.gastro.2013.01.021.
28. Fuchs BC, Hoshida Y, Fujii T, Wei L, Yamada S, Lauwers GY, et al. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. Hepatology. 2014;59(4):1577-90. doi:10.1002/ hep.26898.
29. Rosenbaum J, Blazejewski S, Préaux A-M, Mallat A, Dhumeaux D, Mavier P. Fibroblast growth factor 2 and transforming growth factor β1 interactions in human liver myofibroblasts. Gastroenterology. 1995;109(6):1986-96. doi:10.1016/0016-5085(95)90767-x.
30. Ciccolini F, Svendsen CN. Fibroblast growth factor 2 (FGF-2) promotes acquisition of epidermal growth factor (EGF) responsiveness in mouse striatal precursor cells: identification of neural precursors responding to both EGF and FGF-2. J Neurosci. 1998;18(19):7869-80.
31. Lee K-W, Thiyagarajan V, Sie H-W, Cheng M-F, Tsai M-J, Chia Y-C, et al. Synergistic effect of natural compounds on the fatty acid-induced autophagy of activated hepatic stellate cells. J Nutr Biochem. 2014;25(9):903-13. doi:10.1016/j.jnutbio.2014.04.001.
32. Mannaerts I, Schroyen B, Verhulst S, Van Lommel L, Schuit F, Nyssen M, et al. Gene expression profiling of early hepatic stellate cell activation reveals a role for Igfbp3 in cell migration. PLoS One. 2013;8(12), e84071. doi:10.1371/journal.pone.0084071.
33. Mannaerts I, Leite SB, Verhulst S, Claerhout S, Eysackers N, Thoen LFR et al. The Hippo pathway effector YAP controls mouse hepatic stellate cell activation. Journal of Hepatology. Epub ahead of publication. doi:http:// dx.doi.org/10.1016/j.jhep.2015.04.011.
34. Miano JM, Long X, Fujiwara K. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. 2007;292(1):C70-C81. doi:10.1152/ajpcell.00386.2006.
35. Herrmann J, Haas U, Gressner AM, Weiskirchen R. TGF-β up-regulates serum response factor in activated hepatic stellate cells. Biochim Biophys Acta. 2007;1772(11-12):1250-7. http://dx.doi.org/10.1016/j.bbadis.2007.10.006.
36. Botella LM, Sanz-rodriguez F, Komi Y, Fernandez-l A, Varela E, Garrido-martin EM, et al. TGF-β regulates the expression of transcription factor KLF6 and its splice variants and promotes co-operative transactivation of common target genes through a Smad3-Sp1-KLF6 interaction. Biochem J. 2009;419(2):485-95. doi:10.1042/bj20081434.
37. Kojima S, Hayashi S, Shimokado K, Suzuki Y, Shimada J, Crippa MP, et al. Transcriptional activation of urokinase by the Krüppel-like factor Zf9/COPEB activates latent TGF-β1 in vascular endothelial cells. Blood. 2000;95(4):1309-16.
38. Zhang W, Ou J, Inagaki Y, Greenwel P, Ramirez F. Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor β1 stimulation of a2(I)-collagen (COL1A2) transcription. J Biol Chem. 2000;275(50):39237-45. doi:10.1074/jbc.M003339200.
39. Lee M, Song SU, Ryu JK, Suh JK. Sp1-dependent regulation of the tissue inhibitor of metalloproteinases-1 promoter. J Cell Biochem. 2004;91(6):1260-8. doi:10.1002/jcb.20021.
40. Park J-H, Jo J-H, Kim K-H, Kim S-J, Lee W-R, Park K-K, et al. Antifibrotic effect through the regulation of transcription factor using ring type-Sp1 decoy oligodeoxynucleotide in carbon tetrachloride-induced liver fibrosis. J Gene Med. 2009;11(9):824-33. doi:10.1002/jgm.1355.
41. Chen H, Zhou Y, Chen KQ, An G, Ji SY, Chen QK. Anti-fibrotic effects via regulation of transcription factor Sp1 on hepatic stellate cells. Cell Physiol Biochem. 2012;29(1-2):51-60.
42. Tsukamoto H, She H, Hazra S, Cheng J, Miyahara T. Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation. J Gastroenterol Hepatol. 2006;21:S102-5. doi:10.1111/j.1440-1746.2006.04573.x.
43. Madsen L, Petersen RK, Kristiansen K. Regulation of adipocyte differentiation and function by polyunsaturated fatty acids. Biochim Biophys Acta. 2005;1740(2):266-86. http://dx.doi.org/10.1016/j.bbadis.2005.03.001.
44. Galli A, Crabb D, Price D, Ceni E, Salzano R, Surrenti C, et al. Peroxisome proliferator-activated receptor γ transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology. 2000;31(1):101-8. doi:10.1002/hep.510310117.
45. Miyahara T, Schrum L, Rippe R, Xiong S, Yee HF, Motomura K, et al. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem. 2000;275(46):35715-22. doi:10.1074/jbc.M006577200.
46. Marra F, Efsen E, Romanelli RG, Caligiuri A, Pastacaldi S, Batignani G, et al. Ligands of peroxisome proliferator-activated receptor γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology. 2000;119(2):466-78. http://dx.doi.org/10.1053/ gast.2000.9365.
47. Mikkelsen TS, Xu Z, Zhang X, Wang L, Gimble JM, Lander ES, et al. Comparative epigenomic analysis of murine and human adipogenesis. Cell. 2010;143(1):156-69. doi:10.1016/j.cell.2010.09.006.
48. Wakabayashi K-i, Okamura M, Tsutsumi S, Nishikawa NS, Tanaka T, Sakakibara I, et al. The peroxisome proliferator-activated receptor γ/retinoid X receptor a heterodimer targets the histone modification enzyme PR-Set7/Setd8 gene and regulates adipogenesis through a positive feedback loop. Mol Cell Biol. 2009;29(13):3544-55. doi:10.1128/mcb.01856-08.
49. Salma N, Xiao H, Mueller E, Imbalzano AN. Temporal recruitment of transcription factors and SWI/SNF chromatin-remodeling enzymes during adipogenic induction of the peroxisome proliferator-activated receptor γ nuclear hormone receptor. Mol Cell Biol. 2004;24(11):4651-63. doi:10.1128/ mcb.24.11.4651-4663.2004.
50. Siersbæk R, Nielsen R, John S, Sung M-H, Baek S, Loft A, et al. Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J. 2011;30(8):1459-72. doi:10.1038/ emboj.2011.65.
51. Eeckhoute J, Oger F, Staels B, Lefebvre P. Coordinated regulation of PPARγ expression and activity through control of chromatin structure in adipogenesis and obesity. PPAR Res. 2012;2012:9. doi:10.1155/2012/164140.
52. Imamura M, Inoguchi T, Ikuyama S, Taniguchi S, Kobayashi K, Nakashima N, et al. ADRP stimulates lipid accumulation and lipid droplet formation in murine fibroblasts. Am J Physiol Endocrinol Metab. 2002;283(4):E775-83. doi:10.1152/ajpendo.00040.2002.
53. Lee TF, Mak KM, Rackovsky O, Lin Y-L, Kwong AJ, Loke JC, et al. Downregulation of hepatic stellate cell activation by retinol and palmitate mediated by adipose differentiation-related protein (ADRP). J Cell Physiol. 2010;223(3):648-57. doi:10.1002/jcp.22063.
54. Guimarães ELM, Empsen C, Geerts A, van Grunsven LA. Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells. J Hepatol. 2010;52(3):389-97. http://dx.doi.org/10.1016/j.jhep.2009.12.007.
55. Najimi M, Khuu DN, Lysy PA, Jazouli N, Abarca J, Sempoux C, et al. Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes? Cell Transplant. 2007;16(7):717-28.
56. Coll M, Taghdouini AE, Perea L, Mannaerts I, Vila-Casadesús M, Blaya D et al. Integrative miRNA and gene expression profiling analysis of human quiescent hepatic stellate cells. Sci Rep. 2015;5. doi:10.1038/srep11549.
57. Mannaerts I, Nuytten NR, Rogiers V, Vanderkerken K, van Grunsven LA, Geerts A. Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cells in vitro and in vivo. Hepatology. 2010;51(2):603-14. doi:10.1002/ hep.23334.
58. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31(4), e15. doi:10.1093/nar/gng015.
59. Berardis S, Lombard C, Evraerts J, El Taghdouini A, Rosseels V, Sancho-Bru P, et al. Gene Expression Profiling and Secretome Analysis Differentiate Adult-Derived Human Liver Stem/Progenitor Cells and Human Hepatic Stellate Cells. PLoS ONE. 2014;9(1). doi:10.1371/journal.pone.0086137.